Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the ...
Practice-changing studies in advanced non-small cell lung cancer presented at ASCO 2024 are reviewed by Dr Ticiana Leal, ...
Treatment for lung cancer has changed significantly with immunotherapy, an expert said during the CURE® Educated Patient® ...
Medical Xpress on MSN9d
Slowing inflammation may boost immunotherapy's effectiveness against advanced lung cancerAdding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy ...
In top news on UK stocks, AstraZeneca PLC (GB:AZN) released disappointing results for its cancer drug, Imfinzi, in an ...
The following is a summary of “Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced ...
News Medical on MSN8d
Combination therapy shows great promise as a new strategy against advanced lung cancerAdding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from a small clinical trial led ...
“The results from HERTHENA-Lung01 provide compelling evidence of efficacy of patritumab deruxtecan in heavily pretreated ...
Our findings show it's time to routinely adopt IMRT over 3D-CRT for lung cancer, just like we did for prostate, anal and brain tumors decades ago. The improved precision of IMRT translates into real ...
Zee News on MSN11h
Breakthrough In Lung Cancer Treatment, Study FindsFor patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), standard use of the more accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback